Search

cobas® Zika

Real-time PCR based donor screening test for Zika virus

Zika
cobas® Zika may be an element in emergency preparedness for customers with donors who may have exposure to tropical diseases

Safe donor blood. Safer blood supply.

 

The cobas® Zika test is a real-time PCR-based nucleic acid test (NAT) for the detection of the Zika virus RNA in samples of human plasma intended for use in screening blood donations. This qualitative blood screening assay is for use on the cobas® 6800/8800 Systems.

 

Features and benefits of cobas® Zika

 

  • Proven track record during outbreak in the Americas
  • Detects Asian and African strains
  • Full-process internal control - result integrity
  • Stabilized real-time PCR reagents - no calibration
  • cobas® Zika Control Kit as true external positive control with no effect on result calculation

Related information

Contact Us
Intended use

Intended use

The cobas® Zika test for use on the cobas® 6800 and cobas® 8800 Systems is a qualitative in vitro nucleic acid screening test for the direct detection of Zika virus RNA in human plasma. This test is intended for use to screen donor samples for Zika virus RNA in plasma samples from individual human donors, including donors of whole blood and blood components, and other living donors. This test is also intended for use to screen organ and tissue donors when donor samples are obtained while the donor’s heart is still beating. Plasma from all donors may be screened as individual samples. For donations of whole blood and blood components, plasma samples may be tested individually or in pools comprised of not more than six individual samples. The test is not intended for use as an aid in diagnosis of Zika virus infection. This test is not intended for use on samples of other body fluids. This test is not intended for use on samples of cord blood.

The cobas® Zika test for use on the cobas® 6800 and cobas® 8800 Systems is a qualitative in vitro nucleic acid screening test for the direct detection of Zika virus RNA in human plasma. This test is intended for use to screen donor samples for Zika virus RNA in plasma samples from individual human donors, including donors of whole blood and blood components, and other living donors. This test is also intended for use to screen organ and tissue donors when donor samples are obtained while the donor’s heart is still beating.

 

Plasma from all donors may be screened as individual samples. For donations of whole blood and blood components, plasma samples may be tested individually or in pools comprised of individual samples. The test is not intended for use as an aid in diagnosis of Zika virus infection. This test is not intended for use on samples of cord blood. This test is not intended for use on cadaveric blood specimens.

 

Registration status

US-IVD

CE-IVD

Explore Roche's donor screening solutions

...
    ...
    Image cobas® MPX assay for the detection of HIV, HCV, and HBV in donated blood
    cobas® MPX
    Image of cobas® WNV assay for the detection of West Nile Virus in donated blood
    cobas® WNV
    Image of cobas® DPX assay for the detection of parvovirus B19 and HAV in donated blood
    cobas® DPX
    Image of cobas® HEV assay for the detection of HEV in donated blood
    cobas® HEV
    cobas CV DV
    cobas® CHIKV/DENV
    cobas Babesia test
    cobas® Babesia
    cobas® 6800 System
    cobas® 6800 System Embrace the future of molecular testing with proven PCR performance. Learn about the cobas® 6800 System’s broad menu of high-quality assays, including HIV, HPV, CT/NG, Hepatitis, CMV, WNV, respiratory infections, and more!
    cobas® 8800 System
    cobas® 8800 System Run up to 1,056 tests in an 8-hour shift and experience unparalleled automation - only 3 user interactions per run for up to 4 hours of walk-away time.